Roger Hesselstrand
131 – 140 of 172
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres
- Contribution to journal › Article
-
Mark
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
(2011) 31st European Workshop for Rheumatology Research In Annals of the Rheumatic Diseases 70(Suppl. 2). p.19-19
- Contribution to journal › Published meeting abstract
-
Mark
Concepts of functioning and health important to people with systemic sclerosis: a qualitative study in four European countries
- Contribution to journal › Article
-
Mark
S100A8/A9 in bleomycin-induced skin fibrosis
(2011) 31st European Workshop for Rheumatology Research In Annals of the Rheumatic Diseases 70(Suppl. 2).
- Contribution to journal › Published meeting abstract
-
Mark
The Functional Polymorphism 844 A>G in Fc{alpha}RI (CD89) Does Not Contribute to Systemic Sclerosis or Rheumatoid Arthritis Susceptibility.
- Contribution to journal › Article
-
Mark
Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease
- Contribution to journal › Article
-
Mark
Is there a role for TNF-alpha antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique
- Contribution to journal › Article
-
Mark
Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult
- Contribution to journal › Article
-
Mark
Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
- Contribution to journal › Article
-
Mark
Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis.
- Contribution to journal › Article
